Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Avenir Wellness Solutions, Inc. (CURR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/19/2023 |
8-K
| Quarterly results |
| 03/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 01/17/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ... |
| 08/19/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
8-K
| Quarterly results |
| 01/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 12/03/2021 |
8-K
| Quarterly results |
| 04/29/2021 |
8-K
| Quarterly results |
| 04/06/2021 |
8-K
| Quarterly results |
| 02/25/2021 |
8-K
| Quarterly results |
| 02/12/2021 |
8-K
| Quarterly results |
| 01/06/2021 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/09/2020 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"About SeraLabs SeraLabs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD. SeraLabs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names SeraRelief™, Seratopical™, SeraLabs™, Gordon’s Herbals™ and SeraPets™. SeraLabs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness, and pet care, SeraLabs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level ..." |
|
| 11/02/2020 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...|
Docs:
|
"Security Purchase Agreement",
"Series A Convertible Note",
"Series B Convertible Note",
"Note Purchase Agreement",
"Secured Promissory Note",
"Master Netting Agreement",
"Registration Rights Agreement",
"Leak-Out Agreement",
"CURE Pharmaceutical Closes $10 Million Financing - Funds will support the branding & product launch of Cure’s consumer products by newly acquired Sera Labs and the advancement of CURE’s clinical pharmaceutical pipeline - OXNARD, Calif. -- November 2, 2020 -- CURE Pharmaceutical Holdings , a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes . Axiom Capital Management, Inc. acted as the sole placement agent) in the transaction. CURE may repay the obligations of the Notes in cash only, or the Notes may be converted upon election of the investor at a fixe..." |
|
| 10/29/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/22/2020 |
8-K
| Termination of a Material Definitive Agreement |
| 10/05/2020 |
8-K
| Quarterly results |
| 09/30/2020 |
8-K
| Quarterly results |
| 09/29/2020 |
8-K
| Quarterly results |
| 09/24/2020 |
8-K
| Quarterly results |
| 07/28/2020 |
8-K
| Quarterly results |
| 06/09/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu... |
| 05/11/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/10/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/21/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/14/2019 |
8-K
| Quarterly results |
| 10/04/2019 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...|
Docs:
|
"Plan of Conversion",
"Certificate of Conversion, as filed with the Secretary of State of Delaware on September 30, 2019",
"Certificate of Incorporation, as amended and restated, and as filed with the Secretary of State of Delaware on October 3, 2019",
"Delaware Bylaws",
"Articles of Conversion, as filed with the Secretary of State of Nevada on September 27, 2019" |
|
| 08/08/2019 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/20/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/14/2019 |
8-K
| Appointed a new director |
| 05/01/2019 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/09/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|